CD133, also known as Prominin-1, is expressed on stem cells present in many tissues and tumors. In this work, we have identified and characterized a single-chain variable fragment (scFv) for the efficient and specific recognition of CD133. Phage display was used to develop the scFv from a previously reported anti-CD133 hybridoma clone 7, which was capable of recognizing both glycosylated and non-glycosylated forms of human CD133. The scFv immunostained CD133(+) Caco-2 cells, but not CD133(-/low) U87 cells. Significantly, it immunostained CD133(-) cells transiently transfected with the mouse CD133 gene as well as CD133(+) mouse cells. Co-immunostaining studies in mouse bone marrow cells, using anti-CD133 scFv-FITC and anti-mouse CD133-PE (clone 13A4) commercial antibody, indicated that the epitopes recognized by these reagents partially overlap. Taken together, these results suggest that the scFv can recognize mouse CD133 protein in addition to recognizing human CD133. This new scFv is expected to be valuable both as a molecular diagnostic reagent for identifying CD133(+) cells and as a ligand for targeting therapeutics to CD133(+) tumor-initiating cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527709 | PMC |
| http://dx.doi.org/10.1007/s13346-012-0099-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metalloprotease inhibitors regulate biliary progenitor cells through sDLK1 in organoid models of liver injury.
J Clin Invest
December 2024
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Understanding cell fate regulation in the liver is necessary to advance cell therapies for hepatic disease. Liver progenitor cells (LPC) contribute to tissue regeneration after severe hepatic injury yet signals instructing progenitor cell dynamics and fate are largely unknown. The Tissue Inhibitor of Metalloproteinases, TIMP1 and TIMP3 control the sheddases ADAM10 and ADAM17, key for NOTCH activation.
View Article and Find Full Text PDFAn Injectable Solution for Preservation of Hematopoietic Stem and Progenitors Cells in Hypothermic Condition.
Stem Cell Rev Rep
December 2024
Etablissement Français du Sang Nouvelle Aquitaine, CS21010, Bordeaux-Cedex, 3035, France.
To ensure the preservation of functional hematopoietic stem cells (HSC) and committed progenitor cells (HPC) at + 4 °C in ex vivo expanded cord blood cell products during worldwide transportation and subsequent infusion-without the need for washing and cell concentration-we developed a conservation medium called Stabilizer of Expanded Cells (SEC), composed exclusively of injectable pharmacological products. The in vivo engraftment assay in immunodeficient mice was used to detect primitive HSCs before and after preservation at + 4 °C. In some experiments, a complex phenotype based on CD34, CD38, and CD133 expression was utilized for this purpose.
View Article and Find Full Text PDFStabilization of SQLE mRNA by WTAP/FTO/IGF2BP3-dependent manner in HGSOC: implications for metabolism, stemness, and progression.
Cell Death Dis
December 2024
Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
Article Synopsis
- The study highlights the role of squalene epoxidase (SQLE) in the progression and recurrence of high-grade serous ovarian carcinoma (HGSOC), showing its significant upregulation in cancer samples and association with poor patient outcomes.
- SQLE promotes cancer cell growth by driving proliferation and inhibiting apoptosis, while also enhancing stem-like properties in cancer cells, making it a key factor in maintaining HGSOC stemness.
- Additionally, the research indicates that SQLE mRNA stability is influenced by specific modifications and binding proteins, suggesting that targeting SQLE could be a promising strategy for improving HGSOC prognosis and treatment.
CD133-targeted afatinib nanomicelles for enhanced lung cancer theranostics.
Nanomedicine (Lond)
December 2024
Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Aims: To develop a novel nanomicelle system to target and eradicate CD133-expressing lung cancer stem cells (CSCs) while imaging lung cancer.
Methods: Averatinib nanomicelles with CD133 aptamers incorporated with gadolinium imaging reagents (M-Afa&Gd-CD133) were synthesized. The anticancer and imaging activities of M-Afa&Gd-CD133 were evaluated both in vitro and in vivo.
scRNA-seq revealed transcriptional signatures of human umbilical cord primitive stem cells and their germ lineage origin regulated by imprinted genes.
Sci Rep
November 2024
Laboratory of Regenerative Medicine, Center for Preclinical Studies and Technology, Medical University of Warsaw, Ul. Banacha 1B, Warsaw, Poland.
Article Synopsis
- Researchers identified a specific population of Very Small Embryonic-Like Stem Cells (VSELs) in human postnatal tissues such as bone marrow, peripheral blood, and umbilical cord blood that can differentiate into various tissue stem cells.
- Molecular analysis showed that these VSELs share similar characteristics with embryonic stem cells, including certain gene expressions and patterns of genetic imprinting.
- Using single-cell RNA sequencing, the study found that these human VSELs also exhibit subpopulations related to germline development and are influenced by factors that control differentiation and immune response.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!